Mannitol: Complex Regional Pain Syndrome

Abstract

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a quarterly publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@kumc.edu.

Get full access to this article

View all access options for this article.

References

Zyluk

Puchalski

Treatment of early complex regional pain syndrome type I by a combination of mannitol and dexamethasone. J Hand Surg. 2008; 33E(2): 130–136.

Perez

R.S.

Pragt

Geurts

Zuurmond

W.W.

Patijn

van Kleef

Treatment of patients with complex regional pain syndrome type I with mannitol: a prospective, randomized, placebo-controlled, double-blinded study. J Pain. 2008; 9(8): 678–686.

Tan

ECTH

Tacken

M.C.T.

Groenewoud

J.M.M.

van Goor

Frolke

J.P.

Mannitol as salvage treatment for complex regional pain syndrome type I. Injury. 2010; 41: 955–959.

Perez

R.S.

Zollinger

P.E.

Dijkstra

P.U.

; CRPS-1 Task Force. Evidence based guidelines for complex regional pain syndrome type 1. BMC Neurol. 2010; 10: 20.